---

---

tags : Research    crawled time : 12:20   

save search

---

Talent Acquisition Solutions Market Share Research Report [2023-2030] | 102 Pages – Benzinga
Published: 2023-09-17 (Crawled : 12:20) - spacfeed.com
VHAQ | $10.81 0.0% 990 |

| Email alert Add to watchlist
report acquisition research solutions market

---

Lilly's Retevmo® (selpercatinib) Demonstrates Superior Progression-Free Survival Compared to Approved Multikinase Inhibitors in RET-Mutant Medullary Thyroid Cancer
Published: 2023-08-22 (Crawled : 12:20) - biospace.com/
LLY | News | $731.33 0.69% 0.0% 2.3M |

Health Technology

| 33.48% | O: 0.3% H: 1.19% C: 0.75%
retevmo approved cancer thyroid

---

Halberd’s Successful Completion of Sampling Phase Marks Major Milestone for Project at Mississippi State University (MSU)
Published: 2023-08-22 (Crawled : 12:20) - biospace.com/
HALB | $0.0089 7.14% 370K |

n/a

| 11.11% | O: 0.0% H: 2.22% C: 2.22%
state milestone

---

Nascent Biotech to Begin Phase II Clinical Trials for Brain Cancer
Published: 2023-08-22 (Crawled : 12:20) - biospace.com/
NBIO | $0.0936 15.32% 16K |

| 47.3% | O: 2.29% H: 12.0% C: 10.08%
biotech cancer trials

---

Quince Therapeutics to Acquire EryDel SpA and its Phase 3 Asset Targeting Ataxia-Telangiectasia with No Currently Approved Treatments and Estimated $1+ Billion Peak Sales Opportunity
Published: 2023-07-24 (Crawled : 12:20) - biospace.com/
QNCX | $1.06 0.95% 0.94% 58K |

Professional, Scientific, and T...

| -32.91% | O: -5.7% H: 0.0% C: -22.82%
sales approved acquire therapeutics

---

Bruker Enables Advanced Life-Science and Green-Tech Research in the UK
Published: 2023-07-10 (Crawled : 12:20) - biospace.com/
BRKR | $78.035 0.35% 0.35% 810K |

Health Technology

| 7.02% | O: 0.3% H: 3.03% C: 1.45%
research

---

Harbinger Research Publishes New Research Report on Kaival Brands Innovations Group, Inc.
Published: 2023-06-29 (Crawled : 12:20) - globenewswire.com
KAVL | $3.52 -5.63% -5.97% 270K |

Wholesale Trade

| 344.62% | O: 6.66% H: 2.45% C: -1.22%
report brands research

---

Artelo Biosciences Announces Sponsorship of The William A. Devane Early Career Investigator Award at the 33rd Annual International Cannabinoid Research Society Symposium
Published: 2023-06-28 (Crawled : 12:20) - globenewswire.com
ARTL | News | $1.34 1.9% 1.87% 3.6K |

Health Technology

| -32.29% | O: 2.08% H: 0.0% C: -2.04%
award symposium research

---

LadRx Completes Non-Dilutive Financing Transaction for up to $11 Million with XOMA Corporation
Published: 2023-06-22 (Crawled : 12:20) - biospace.com/
XOMA | $25.61 0.51% 0.51% 7.2K |

Health Technology

| 39.04% | O: 0.7% H: 4.87% C: 3.48%
corporation

---

Roivant Reports Chronic Period Data for RVT-3101 from the TUSCANY-2 Phase 2b Study in Ulcerative Colitis, Demonstrating Improved Efficacy from the Induction to Chronic Period
Published: 2023-06-22 (Crawled : 12:20) - biospace.com/
ROIV | $10.61 1.43% 1.41% 5.3M |

Manufacturing

| 11.23% | O: 5.46% H: 7.76% C: -0.8%
rvt-3101 study

---

Horizon Therapeutics plc Announces Positive Topline Data from Phase 3 Clinical Trial (OPTIC-J) in Japan Evaluating TEPEZZA® (teprotumumab-trbw) for the Treatment of Active Thyroid Eye Disease (TED)
Published: 2023-06-22 (Crawled : 12:20) - biospace.com/
HZNP | $116.3 0.03% 29M |

Health Technology

| 14.47% | O: -0.25% H: 0.75% C: 0.04%
tepezza disease active japan positive treatment thyroid topline eye trial therapeutics

---

Dyadic Announced an MoU with Bangladesh’s State-Owned Pharmaceutical Company to Facilitate Biopharmaceutical Research and Biomanufacturing Capacity
Published: 2023-06-21 (Crawled : 12:20) - globenewswire.com
DYAI A | $1.58 -0.63% -0.63% 8.5K |

Health Technology

| -25.73% | O: 2.71% H: 1.17% C: -2.17%
capacity research

---

Milestone Pharmaceuticals Announces Publication of Results from Phase 3 RAPID Clinical Trial of Etripamil Nasal Spray in Patients with PSVT in The Lancet
Published: 2023-06-20 (Crawled : 12:20) - biospace.com/
MIST | $1.69 3.05% 2.96% 35K |

Health Technology

| -53.43% | O: -0.86% H: 3.75% C: -0.86%
etripamil lancet rapid publication pharmaceuticals spray trial results milestone

---

NLS Pharmaceutics Announces Company Update Webcast
Published: 2023-06-19 (Crawled : 12:20) - biospace.com/
NLSP | $0.1211 -8.74% -9.58% 570K |

| Email alert Add to watchlist
update

---

Datasea Joins Forces with Industry Leaders to Publish Research Report on 5G Messaging Services in the Express Delivery Industry
Published: 2023-06-13 (Crawled : 12:20) - globenewswire.com
DTSS | News | $7.29 0.69% 0.69% 18K |

Technology Services

| 577.94% | O: -1.47% H: 4.59% C: 0.0%
services report express research

---

Panbela Announces Sponsored Research Agreement to Evaluate Polyamine Metabolic Inhibitor Therapy in Combination with CAR-T Cell Therapy
Published: 2023-06-13 (Crawled : 12:20) - globenewswire.com
PBLA | News | $0.42 -6.31% 260K |

Professional, Scientific, and T...

| -92.77% | O: 13.23% H: 22.83% C: -16.44%
metabolic cell research car-t agreement therapy

---

Bionano Announces 2023 Winners of its Innovator Research Grant Program
Published: 2023-06-12 (Crawled : 12:20) - globenewswire.com
BNGO | $0.7544 0.59% 0.58% 870K |

Health Technology

| 2.87% | O: -1.19% H: 5.07% C: 2.04%
research grant program

---

Eyal Peso, CEO of Smart Materials Company Gauzy, Ltd. Joins Board of Directors of Smart Glass Leader Research Frontiers
Published: 2023-06-05 (Crawled : 12:20) - globenewswire.com
REFR | $1.53 0.0% 25K |

Electronic Technology

| -11.11% | O: 2.92% H: 5.11% C: -3.41%
ceo research smart glass

---

Gaia Announces Participation in Water Tower Research Fireside Chat Series on June 13th at 2:00 p.m. ET
Published: 2023-06-05 (Crawled : 12:20) - globenewswire.com
GAIA | $3.885 -1.15% -1.16% 48K |

Commercial Services

| 57.79% | O: 0.83% H: 1.62% C: 0.4%
water research

---

Phase 3 SWOG Cancer Research Network trial, led by a City of Hope researcher, demonstrates one-year progression-free survival in 94% of patients with Stage 3 or 4 classic Hodgkin lymphoma who received a checkpoint inhibitor combined with chemotherapy
Published: 2023-06-04 (Crawled : 12:20) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320 |

Communications

| Email alert Add to watchlist
hope cancer city research network

---

Gainers vs Losers

75%

25%

Top 10 Gainers

MTTR | News M | $4.78 174.71% 63.6% 72M |

AGBA | $2.565 105.2% 51.27% 200M |

Finance

MLEC | $2.44 74.29% 42.62% 78M |

n/a

EDBL | News | $6.28 67.02% 40.13% 16M |

ATGL | $2.91 48.81% 32.8% 180K |

ZAPP | $0.2175 47.16% 32.05% 16M |

n/a

ONFO | $0.6075 38.38% 27.74% 7.3M |

n/a

VIVK | $1.48 38.32% 27.7% 530K |

Professional, Scientific, and T...

MNTS | $0.5 35.69% 26.3% 4.8M |

SDIG A | $3.635 35.13% 26.0% 1M |

---

Your saved searches

---